EAM
RNAC icon

Erste Asset Management’s Cartesian Therapeutics RNAC Stock Holding History

Erste Asset Management’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$227K Sell
23,566
-198,139
-89% -$1.47M ﹤0.01% 553
2026
Q1 		$1.3M Sell
221,705
-50,000
-18% -$356K 0.01% 421
2025
Q4 		$1.96M Buy
271,705
+11,694
+4% +$94.6K 0.02% 350
2025
Q3 		$2.56M Hold
260,011
– – 0.02% 325
2025
Q2 		$2.7M Hold
260,011
– – 0.02% 357
2025
Q1 		$3.43M Buy
260,011
+86,445
+50% +$1.54M 0.04% 255
2024
Q4 		$3.26M Hold
173,566
– – 0.04% 278
2024
Q3 		$2.8M Buy
173,566
+51,333
+42% +$802K 0.03% 282
2024
Q2 		$3.31M Buy
122,233
+15,163
+14% +$362K 0.04% 266
2024
Q1 		$2.09M Buy
107,070
+2,837
+3% +$60.1K 0.03% 299
2023
Q4 		$2.16M Buy
104,233
+20,000
+24% +$597K 0.03% 289
2023
Q3 		$2.69M Buy
84,233
+6,666
+9% +$223K 0.05% 250
2023
Q2 		$2.61M Buy
77,567
+8,334
+12% +$298K 0.05% 255
2023
Q1 		$2.88M Hold
69,233
– – 0.06% 259
2022
Q4 		$2.35M Hold
69,233
– – 0.05% 266
2022
Q3 		$3.4M Sell
69,233
-16,667
-19% -$915K 0.08% 238
2022
Q2 		$3.37M Buy
85,900
+18,333
+27% +$544K 0.07% 245
2022
Q1 		$2.5M Buy
67,567
+27,234
+68% +$1.7M 0.05% 272
2021
Q4 		$4.04M Buy
+40,333
New +$4.34M 0.07% 228

Other funds holding RNAC

Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Erste Asset Management's RNAC Position: Q2 2026 in Review

Erste Asset Management reduced its Cartesian Therapeutics (RNAC) stake by 89% in Q2 2026, selling an estimated $1.47M and leaving 23,566 shares worth $227K. The position accounts for ﹤0.01% of the portfolio, ranked #553.

Erste Asset Management first reported a position in RNAC in Q4 2021 and has held it in 19 quarters since. The position peaked at $4.04M in Q4 2021. 95 funds tracked by Wall St. Rank hold RNAC as of Q2 2026.

  • Erste Asset Management held 23,566 shares of Cartesian Therapeutics worth $227K as of Q2 2026.
  • Erste Asset Management sold 198,139 Cartesian Therapeutics shares in Q2 2026, an estimated $1.47M.
  • Cartesian Therapeutics made up ﹤0.01% of Erste Asset Management's portfolio in Q2 2026, its #553 holding.
  • Erste Asset Management first reported a position in Cartesian Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • Erste Asset Management's Cartesian Therapeutics position peaked at $4.04M in Q4 2021.
  • 95 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.